Gastroesophageal reflux
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Mothers over 18 years of age with full term newborns greater than or equal to 37 weeks of gestational age and less than 42 weeks of GI, healthy, with an Apgar score greater than 7 at the fifth minute, and with age-appropriate birth weight gestational
Exclusion criteria
Exclusion criteria: Mothers with impaired comprehension and verbal language will be excluded. It will be excluded newborns with Apgar less than seven in the fifth minute, malformation, neurological disease, congenital infection, and infants who throughout the study have a diagnosis of gastroesophageal reflux disease, with a history of aspiration, apnea, growth restriction , weight loss and difficulty in swallowing, allergy to cow's milk protein, in this study considered as presence of blood in the stool, inflammation of the anus, severe atopic dermatitis and use of formulas to treat food allergy; history of seizure and or diagnosis of metabolic disease and use of medications such as domperidone, bromopride, metoclopramide, omeprazole and ranitidine.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in the number of infantile regurgitations, verified through the mothers' diary filling and their report in the last 24 hours before the consultation. | — |
Secondary
| Measure | Time frame |
|---|---|
| secondary outcome 1 - reduction in the crying time of the infant, whose method of evaluation will be through the mothers' diary and their report in the last 24 hours before the consultation. ;secondary outcome 2 - reduction in the level of maternal anxiety, the evaluation method will be through the State Anxiety Inventory (IDATE) | — |
Countries
Brazil
Contacts
Universidade Federal de Pernambuco